- Home
- SUPN vs VICR Comparison
SUPN vs VICR Comparison
Compare SUPN & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- VICR
- Stock Information
- Founded
- SUPN 2005
- VICR 1981
- Country
- SUPN United States
- VICR United States
- Employees
- SUPN N/A
- VICR N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- VICR Industrial Machinery/Components
- Sector
- SUPN Health Care
- VICR Technology
- Exchange
- SUPN Nasdaq
- VICR Nasdaq
- Market Cap
- SUPN 1.9B
- VICR 1.9B
- IPO Year
- SUPN 2012
- VICR N/A
- Fundamental
- Price
- SUPN $33.56
- VICR $45.81
- Analyst Decision
- SUPN Hold
- VICR Hold
- Analyst Count
- SUPN 2
- VICR 2
- Target Price
- SUPN $36.00
- VICR $43.00
- AVG Volume (30 Days)
- SUPN 681.6K
- VICR 383.4K
- Earning Date
- SUPN 08-05-2025
- VICR 07-22-2025
- Dividend Yield
- SUPN N/A
- VICR N/A
- EPS Growth
- SUPN N/A
- VICR 576.06
- EPS
- SUPN 1.11
- VICR 1.45
- Revenue
- SUPN $667,997,000.00
- VICR $379,346,000.00
- Revenue This Year
- SUPN N/A
- VICR $17.22
- Revenue Next Year
- SUPN $15.74
- VICR $9.90
- P/E Ratio
- SUPN $30.78
- VICR $31.62
- Revenue Growth
- SUPN 11.82
- VICR 2.46
- 52 Week Low
- SUPN $27.05
- VICR $34.27
- 52 Week High
- SUPN $40.28
- VICR $65.70
- Technical
- Relative Strength Index (RSI)
- SUPN 57.11
- VICR 48.15
- Support Level
- SUPN $32.94
- VICR $45.06
- Resistance Level
- SUPN $34.21
- VICR $63.00
- Average True Range (ATR)
- SUPN 1.06
- VICR 2.78
- MACD
- SUPN 0.04
- VICR -0.27
- Stochastic Oscillator
- SUPN 56.90
- VICR 11.02
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.